106 related articles for article (PubMed ID: 23796964)
1. Multinucleation regulated by the Akt/PTEN signaling pathway is a survival strategy for HepG2 cells.
Mukherjee A; Misra S; Howlett NG; Karmakar P
Mutat Res; 2013 Aug; 755(2):135-40. PubMed ID: 23796964
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of PTEN is responsible for the survival of Hep G2 cells in response to etoposide-induced damage.
Mukherjee A; Samanta S; Karmakar P
Mutat Res; 2011 Oct; 715(1-2):42-51. PubMed ID: 21784088
[TBL] [Abstract][Full Text] [Related]
3. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
Martelli AM; Evangelisti C; Chappell W; Abrams SL; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo V; Ruvolo P; Kempf CR; Steelman LS; McCubrey JA
Leukemia; 2011 Jul; 25(7):1064-79. PubMed ID: 21436840
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H; Ooi LL; Hui KM
Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
[TBL] [Abstract][Full Text] [Related]
5. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
6. Activation of Akt and ERK signalling pathways induced by etoposide confer chemoresistance in gastric cancer cells.
Liu SQ; Yu JP; Yu HG; Lv P; Chen HL
Dig Liver Dis; 2006 May; 38(5):310-8. PubMed ID: 16527552
[TBL] [Abstract][Full Text] [Related]
7. CGK733 enhances multinucleated cell formation and cytotoxicity induced by taxol in Chk1-deficient HBV-positive hepatocellular carcinoma cells.
Wang H; Zuo B; Wang H; Ren L; Yang P; Zeng M; Duan D; Liu C; Li M
Biochem Biophys Res Commun; 2012 May; 422(1):103-8. PubMed ID: 22564734
[TBL] [Abstract][Full Text] [Related]
8. PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells.
Tian T; Nan KJ; Wang SH; Liang X; Lu CX; Guo H; Wang WJ; Ruan ZP
Carcinogenesis; 2010 Jul; 31(7):1211-9. PubMed ID: 20430845
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of PTEN perturbs genomic stability via activation of Akt and down-regulation of Rad51 in human embryonic kidney cells.
Mukherjee A; Karmakar P
Mol Carcinog; 2013 Aug; 52(8):611-8. PubMed ID: 22488521
[TBL] [Abstract][Full Text] [Related]
10. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L
Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779
[TBL] [Abstract][Full Text] [Related]
11. Novel 2'-substituted, 3'-deoxy-phosphatidyl-myo-inositol analogues reduce drug resistance in human leukaemia cell lines with an activated phosphoinositide 3-kinase/Akt pathway.
Tabellini G; Tazzari PL; Bortul R; Billi AM; Conte R; Manzoli L; Cocco L; Martelli AM
Br J Haematol; 2004 Aug; 126(4):574-82. PubMed ID: 15287952
[TBL] [Abstract][Full Text] [Related]
12. PTEN enhances G2/M arrest in etoposide-treated MCF‑7 cells through activation of the ATM pathway.
Zhang R; Zhu L; Zhang L; Xu A; Li Z; Xu Y; He P; Wu M; Wei F; Wang C
Oncol Rep; 2016 May; 35(5):2707-14. PubMed ID: 26986476
[TBL] [Abstract][Full Text] [Related]
13. Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death.
Yu HG; Ai YW; Yu LL; Zhou XD; Liu J; Li JH; Xu XM; Liu S; Chen J; Liu F; Qi YL; Deng Q; Cao J; Liu SQ; Luo HS; Yu JP
Int J Cancer; 2008 Jan; 122(2):433-43. PubMed ID: 17935137
[TBL] [Abstract][Full Text] [Related]
14. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
[TBL] [Abstract][Full Text] [Related]
15. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
Jacob S; Aguado M; Fallik D; Praz F
Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
[TBL] [Abstract][Full Text] [Related]
16. The G2 block induced by DNA damage: a caffeine-resistant component independent of Cdc25C, MPM-2 phosphorylation, and H1 kinase activity.
Barratt RA; Kao G; McKenna WG; Kuang J; Muschel RJ
Cancer Res; 1998 Jun; 58(12):2639-45. PubMed ID: 9635591
[TBL] [Abstract][Full Text] [Related]
17. Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma.
Marsh Durban V; Deuker MM; Bosenberg MW; Phillips W; McMahon M
J Clin Invest; 2013 Dec; 123(12):5104-18. PubMed ID: 24200692
[TBL] [Abstract][Full Text] [Related]
18. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M
Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337
[TBL] [Abstract][Full Text] [Related]
19. PTEN modulates hepatitis B virus-X protein induced survival signaling in Chang liver cells.
Kang-Park S; Im JH; Lee JH; Lee YI
Virus Res; 2006 Dec; 122(1-2):53-60. PubMed ID: 16872708
[TBL] [Abstract][Full Text] [Related]
20. Hexabromocyclododecane and polychlorinated biphenyls increase resistance of hepatocellular carcinoma cells to cisplatin through the phosphatidylinositol 3-kinase/protein kinase B pathway.
An J; Wang X; Guo P; Zhong Y; Zhang X; Yu Z
Toxicol Lett; 2014 Aug; 229(1):265-72. PubMed ID: 24960055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
